Skip to main content

The innovation squeeze across the therapeutic spectrum means that brands, portfolios and corporations need to continuously identify and leverage new sources of value. Rooted in competitive intelligence, we deliver commercially framed insights & analysis that give our clients the means to execute on strategy and tactics, confidently and decisively.

We have extensive experience in deploying the optimal combination of secondary and primary research approaches to iteratively develop and test hypotheses. Our tailored workshops help your team reflect and unite around complex decision points.

Our global network of expert sources provides unique competitive intelligence insights, enabling us to deeply understand topics, pressure-test assumptions and support in delivering strategic recommendations

From monitoring the landscape for real time competitive insights that can move the needle on critical brand-level investment decisions, to deep dive/ad hoc research to address a specific competitive threat or opportunity, we can support your business.

Our Core Capabilities

Our team has deep experience in partnering to deliver bespoke & holistic competitive intelligence that are tailored to our client’s priorities and deliver actionable insights

Asset/Franchise Monitoring

Continuous and holistic understanding of competitor activities and market events to drive confident decision making

  • R&D and Commercial Competitor Tactics and Strategies
  • Landscape Evolution
  • Clinical Trial Development
View Case Study

Global Conference Coverage

On the ground support to capture, interpret and communicate key insights as soon as they are released into the medical community

  • Comprehensive Pre, Peri and Post conference support
  • Real-time Competitor Data Analysis
  • Medical Advisory Board Support
View Case Study

Competitor Deep Dives & Benchmarking

Detailed, bespoke research and analysis exercises to help inform more complex or demanding strategic questions and associated investments

  • Product/TA Strategy Evaluation
  • Technical Landscape Assessments
  • Value Proposition Assessments
View Case Study

Competitor Evaluation Exercises/Workshops

Designing and facilitating analytical exercises to generate novel perspectives, refine or enhance tactical planning and ensure team alignment

  • Competitor Simulation Activities
  • Portfolio Prioritization Exercises
  • Scenario Analysis and Development
View Case Study

Our Hybrid Offerings

We specialize in delivering “hybrid” engagements that merge the competitive context with strategic priorities of medical, commercial, and access stakeholders.

Early Clinical Strategy

Laying the groundwork to maximize value and potential during the development process

  • Lead Indication Prioritisation
  • Early Indication Selection
  • Trend analysis and opportunity assessment
  • Pricing assessments (analogue & qual. PMR)
View Case Study

Pre-Launch Excellence

Ensuring products can achieve their full potential and deliver the most benefits to patients

  • Launch Excellence Strategy
  • Portfolio Strategy
  • Value Proposition & Objection handler
  • Localization of access strategies
  • Primary Market Research (Payer & KOL)
View Case Study

Cross Portfolio Strategies

Holistic wrap-around services to complement broader strategic objectives

  • R&D Process Optimisation/Acceleration,
  • Governance
  • Sales Force Effectiveness,
  • Patient Support Programs,
  • Beyond-the-Pill tactics
View Case Study

Lifecycle Management

Navigate key decision points across the entire lifecycle to create opportunities for growth

  • Established Brand Optimisation
  • Localization of Access Strategies & Execution Support
  • Mid-Late Lifecyle (LLC) Optimisation
  • LOE Preparation & Market Share Erosion
View Case Study

Our TA Expertise

Our broad Therapeutic expertise results from a range of country and region-specific projects as well as global assessments for a wide variety of clients. 

Oncology & Hematology

  • Pan Tumor & Biomarker Strategy
  • Early Pipeline Development
  • Cell and gene therapy

Infectious Diseases

  • Long-acting Modalities
  • Patient centric Clinical development and Marketing
  • Dual Focus on Prevention and Treatment

CVRM

  • Multi-factorial patient identification and monitoring
  • Innovative treatment technology, including gene therapy and MedTech
  • Personalized medicine and digital health adoption 

Neurology

  • Diagnostic Pathway Mapping, from Imaging to Fluid Biomarkers
  • New Disease Modifying Therapies in Hard-to-Treat Indications
  • Expanded Care Pathways 

Other: Immunology, Pulmonology/Respiratory, Rare Diseases, Ophthalmology, Women’s Health, Biosimilars, Cross-Portfolio

Contact information

Fill in the contact form and a member of your team will get back to you

info@eradigm.com

Eradigm Consulting

Work.Life
6-7 St Cross St,
London, EC1N 8UB